Breast cancer negative for ERs, progesterone receptors, and excess human epidermal growth factor receptor 2 protein (triple-negative breast cancer, TNBC) is responsible for 15–20% of all breast cancer cases (Lee et al., 2019). This evidence concerns the gene ERBB2 and breast carcinoma.